TY - JOUR
T1 - Flat Oral Glucose Tolerance Test during Pregnancy
T2 - Maternal Characteristics and Risk for Adverse Outcomes
AU - Naeh, Amir
AU - Wilkof-Segev, Renana
AU - Jaffe, Anat
AU - Maor-Sagie, Esther
AU - Hallak, Mordechai
AU - Gabbay-Benziv, Rinat
N1 - Publisher Copyright:
©2021 by the American Diabetes Association.
PY - 2021/6/1
Y1 - 2021/6/1
N2 - Flat oral glucose tolerance test (OGTT) curve is characterized by low glucose levels, seemingly nonresponsive to glucose load. Few studies have explored flat OGTT during pregnancy and have yielded conflicting results, some suggesting risk for fetal growth restriction. This study evaluated the characteristics and perinatal outcomes of women with a flat OGTT during pregnancy. We found that a flat OGTT curve occurs in younger, leaner pregnant women. Also, flat OGTT curve was significantly associated with a male fetus and higher levels of pregnancy-associated plasma protein A at the first-trimester screening. Although flat OGTT can possibly reflect some degree of hyperinsulinemia, it is generally not associated with adverse maternal or neonatal outcomes.
AB - Flat oral glucose tolerance test (OGTT) curve is characterized by low glucose levels, seemingly nonresponsive to glucose load. Few studies have explored flat OGTT during pregnancy and have yielded conflicting results, some suggesting risk for fetal growth restriction. This study evaluated the characteristics and perinatal outcomes of women with a flat OGTT during pregnancy. We found that a flat OGTT curve occurs in younger, leaner pregnant women. Also, flat OGTT curve was significantly associated with a male fetus and higher levels of pregnancy-associated plasma protein A at the first-trimester screening. Although flat OGTT can possibly reflect some degree of hyperinsulinemia, it is generally not associated with adverse maternal or neonatal outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85123060968&partnerID=8YFLogxK
U2 - 10.2337/cd20-0099
DO - 10.2337/cd20-0099
M3 - Article
C2 - 34421208
AN - SCOPUS:85123060968
SN - 0891-8929
VL - 39
SP - 313
EP - 319
JO - Clinical Diabetes
JF - Clinical Diabetes
IS - 3
ER -